Published: May 02, 2010
Older Women with Diabetes Face Higher Risk for Colon Cancer
NEW ORLEANS - (BUSINESS WIRE) - A research team led by Mayo Clinic physicians has found that older women
with diabetes face a more than doubled risk for some types of colorectal
cancer. The findings are being presented at Digestive Disease Week 2010,
the annual meeting of the American Gastroenterological Association.
Colorectal
cancer (http://www.mayoclinic.org/colon-cancer/)
remains the third-leading cause of cancer deaths among women in the
United States. Diabetes has been identified as a colon cancer risk
factor, but the mechanisms aren't completely understood. For this
population-based cohort study, researchers examined data from 37,695
participants of the Iowa Women's Health Study (IWHS), which enrolled
women ages 55â69 in 1986 and remains ongoing. Of these women, 2,361
reported a diagnosis of Type 2 diabetes and 1,200 developed colorectal
cancer.
To find the links between colorectal cancer and diabetes, the
researchers worked with regional pathology laboratories to obtain tumor
tissue samples from IWHS participants who were diagnosed with colorectal
cancer. They linked the tissue samples with other IWHS data, looking for
cancer pathways and risk factors, and whether those risk factors were
associated with three different molecular markers: microsatellite
instability (MSI), CpG island methylation (CIMP), and BRAF gene
mutations.
"Diabetes was more strongly associated with the MSI-high, CIMP-positive
and BRAF-mutation cancer subtypes in this group of older women," says
Mayo Clinic gastroenterologist Paul
Limburg, M.D. (http://www.mayoclinic.org/bio/10658084.htm).
Dr. Limburg explains that diabetes appeared to confer a greater than
twofold increase in risk for these molecularly-defined tumors, compared
to women without diabetes.
"Knowing that diabetic women have these findings should help to
facilitate more appropriate colorectal cancer prevention and treatment
options," says Anthony Razzak, M.D., a Mayo Clinic research fellow and
presenter at the conference. "Our findings may lead to new strategies
for colon cancer screening, chemotherapy and chemoprevention in women
with diabetes."
"From a research perspective, this information allows us to clarify how
environmental exposures and other risk factors might effect tumor
formation at a molecular level," says Dr. Razzak. For future projects,
the researchers will work to understand more about the biology of
colorectal cancer and how it is influenced by diabetes, as well as other
chronic conditions and exposures. They hope to use that information to
improve patient care.
"Unfortunately, diabetes and colon cancer are both very common in the
United States, so making links between these disorders has substantial
public health implications," says Dr. Limburg.
Mayo Clinic's Division
of Gastroenterology and Hepatology (http://www.mayoclinic.org/gi-rst)
has been ranked No. 1 in the U.S. News & World Report Honor Roll of Top
Hospitals since the rankings began 20 years ago.
Collaboration
The study was funded by the National Cancer Institute. Additional Mayo
Clinic co-authors are Amy Oxtenko, M.D.; Robert Vierkant; Lori Tillmans;
Alice Wang; Susan Slager, Ph.D; Thomas Smyrk, M.D.; Stephen Thibodeau,
Ph.D.; and James Cerhan, M.D., Ph.D. Co-authors from other institutions
are Daniel Weisenberger, Ph.D., and Peter Laird, Ph.D., both of the
University of Southern California Epigenome Center; Charles Lynch, M.D.,
Ph.D., University of Iowa College of Public Health, Iowa City; Kristin
Anderson, Ph.D., and Lisa Harnack, Ph.D., both of the University of
Minnesota Cancer Center, Minneapolis; Robert Haile, Ph.D., of the
University of Southern California School of Medicine, Los Angeles; and
John Potter, M.D., Fred Hutchinson Cancer Research Center, Seattle.
To request an appointment at Mayo Clinic, please call 480-422-1490 for
the Arizona campus, 904-494-6484 for the Florida campus, or 507-216-4573
for the Minnesota campus.
About Mayo Clinic
For more than 100 years, millions of people from all walks of life have
found answers at Mayo Clinic. These patients tell us they leave Mayo
Clinic with peace of mind knowing they received care from the world's
leading experts. Mayo Clinic is the first and largest integrated,
not-for-profit group practice in the world. At Mayo Clinic, a team of
specialists is assembled to take the time to listen, understand and care
for patients' health issues and concerns. These teams draw from more
than 3,700 physicians and scientists and 50,100 allied staff that work
at Mayo Clinic's campuses in Minnesota, Florida, and Arizona; and
community-based providers in more than 70 locations in southern
Minnesota., western Wisconsin and northeast Iowa. These locations treat
more than half a million people each year. To best serve patients, Mayo
Clinic works with many insurance companies, does not require a physician
referral in most cases and is an in-network provider for millions of
people. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news.
For information about research and education visit www.mayo.edu.
MayoClinic.com (www.mayoclinic.com)
is available as a resource for your general health information.

Mayo Clinic
Amy Tieder
507-284-5005 (days)
507-284-2511
(evenings)
e-mail: newsbureau@mayo.edu
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News